| Attribute |
Value |
| 52 Week Change |
-0.88158536 |
| Address1 |
455 East Medical Center Boulevard |
| Address2 |
Suite 300 |
| All Time High |
1,100.0 |
| All Time Low |
0.62 |
| Ask |
1.46 |
| Ask Size |
1 |
| Average Daily Volume10 Day |
132,630 |
| Average Daily Volume3 Month |
209,326 |
| Average Volume |
209,326 |
| Average Volume10Days |
132,630 |
| Beta |
1.741 |
| Bid |
1.17 |
| Bid Size |
1 |
| Book Value |
0.762 |
| City |
Houston |
| Compensation As Of Epoch Date |
1,767,139,200 |
| Country |
United States |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
0.971 |
| Current Ratio |
2.643 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,790,726,400 |
| Day High |
1.04 |
| Day Low |
0.95 |
| Debt To Equity |
31.536 |
| Display Name |
FibroBiologics |
| Dividend Yield |
0.0 |
| Earnings Timestamp End |
1,755,201,600 |
| Earnings Timestamp Start |
1,755,201,600 |
| Ebitda |
-16,466,000 |
| Ebitda Margins |
0.0 |
| Enterprise To Ebitda |
-0.268 |
| Enterprise Value |
4,412,105 |
| Eps Current Year |
-3.0 |
| Eps Forward |
-3.25 |
| Eps Trailing Twelve Months |
-5.01 |
| Esg Populated |
0 |
| Exchange |
NCM |
| Exchange Data Delayed By |
15 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fifty Day Average |
1.33474 |
| Fifty Day Average Change |
-0.36374003 |
| Fifty Day Average Change Percent |
-0.2725175 |
| Fifty Two Week Change Percent |
-88.15854 |
| Fifty Two Week High |
9.6 |
| Fifty Two Week High Change |
-8.629001 |
| Fifty Two Week High Change Percent |
-0.8988542 |
| Fifty Two Week Low |
0.62 |
| Fifty Two Week Low Change |
0.351 |
| Fifty Two Week Low Change Percent |
0.566129 |
| Fifty Two Week Range |
0.62 - 9.6 |
| Financial Currency |
USD |
| First Trade Date Milliseconds |
1,706,711,400,000 |
| Float Shares |
5,191,460 |
| Forward Eps |
-3.25 |
| Forward P E |
-0.29876924 |
| Free Cashflow |
-8,368,000 |
| Full Exchange Name |
NasdaqCM |
| Full Time Employees |
15 |
| Fullday Change |
-0.028999984 |
| Fullday Change Percent |
-2.9322534 |
| Fullday Price |
0.971 |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Gross Margins |
0.0 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.13737 |
| Held Percent Institutions |
0.15254 |
| Implied Shares Outstanding |
7,081,701 |
| Industry |
Biotechnology |
| Industry Disp |
Biotechnology |
| Industry Key |
biotechnology |
| Ipo Expected Date |
2,024-01-31 |
| Is Earnings Date Estimate |
1 |
| Language |
en-US |
| Last Fiscal Year End |
1,767,139,200 |
| Last Split Date |
1,774,828,800 |
| Last Split Factor |
1:20 |
| Long Business Summary |
FibroBiologics, Inc., a clinical-stage biotechnology company, engages in the development and commercialization of fibroblast-based therapies for patients suffering from chronic diseases. The company's product pipeline includes CYWC628 which has completed pre-clinical trial for the treatment of wound healing; CYMS101 which has completed Phase 1 trial for the treatment of multiple sclerosis; CybroCell for the treatment of degenerative disc disease; and CYPS317 for the treatment of psoriasis. It also develops early-stage research products, including CYTER915 to treat the human longevity; and TCB190 for the treatment of certain cancers. FibroBiologics, Inc. was incorporated in 2021 and is headquartered in Houston, Texas. |
| Long Name |
FibroBiologics, Inc. |
| Market |
us_market |
| Market Cap |
6,876,332 |
| Market State |
CLOSED |
| Max Age |
86,400 |
| Message Board Id |
finmb_1758633149 |
| Most Recent Quarter |
1,782,777,600 |
| Net Income To Common |
-18,139,000 |
| Next Fiscal Year End |
1,798,675,200 |
| Non Diluted Market Cap |
9,252,412 |
| Number Of Analyst Opinions |
2 |
| Open |
1.02 |
| Operating Cashflow |
-14,790,000 |
| Operating Margins |
0.0 |
| Phone |
281 671 5150 |
| Previous Close |
1.0 |
| Price Eps Current Year |
-0.32366666 |
| Price Hint |
4 |
| Price To Book |
1.2742782 |
| Profit Margins |
0.0 |
| Quick Ratio |
1.588 |
| Quote Source Name |
Delayed Quote |
| Quote Type |
EQUITY |
| Recommendation Key |
none |
| Region |
US |
| Regular Market Change |
-0.028999984 |
| Regular Market Change Percent |
-2.8999984 |
| Regular Market Day High |
1.04 |
| Regular Market Day Low |
0.95 |
| Regular Market Day Range |
0.95 - 1.04 |
| Regular Market Open |
1.02 |
| Regular Market Previous Close |
1.0 |
| Regular Market Price |
0.971 |
| Regular Market Time |
1,792,180,800 |
| Regular Market Volume |
35,971 |
| Return On Assets |
-0.95765 |
| Return On Equity |
-6.6008 |
| Sand P52 Week Change |
0.13723719 |
| Sector |
Healthcare |
| Sector Disp |
Healthcare |
| Sector Key |
healthcare |
| Shares Outstanding |
7,081,701 |
| Shares Percent Shares Out |
0.075100005 |
| Shares Short |
522,114 |
| Shares Short Previous Month Date |
1,788,134,400 |
| Shares Short Prior Month |
413,742 |
| Short Name |
FibroBiologics, Inc. |
| Short Percent Of Float |
0.0787 |
| Short Ratio |
2.04 |
| Source Interval |
15 |
| State |
TX |
| Symbol |
FBLG |
| Target High Price |
19.0 |
| Target Low Price |
6.0 |
| Target Mean Price |
12.5 |
| Target Median Price |
12.5 |
| Total Cash |
3,515,000 |
| Total Cash Per Share |
0.528 |
| Total Debt |
1,462,000 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
0.0 |
| Trailing Annual Dividend Yield |
0.0 |
| Trailing Eps |
-5.01 |
| Trailing Peg Ratio |
None |
| Triggerable |
1 |
| Two Hundred Day Average |
2.634975 |
| Two Hundred Day Average Change |
-1.663975 |
| Two Hundred Day Average Change Percent |
-0.6314956 |
| Type Disp |
Equity |
| Volume |
35,971 |
| Website |
https://fibrobiologics.com |
| Zip |
77,598 |